Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid — Stella

Home/Bullous Pemphigoid/Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid

View on ClinicalTrials.gov

Recruiting

Back to Bullous Pemphigoid trials

Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Chu Reims, Reims

Key details

Sponsor

CHU de Reims

Enrollment target

~140 participants

Started

February 2022

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.